Both G-CSF and GM-CSF are used in neutropenia related to cancer treatment (NCT04166604, NCT03102606, NCT00002950); however, as was shown in mouse models, both may induce granulocytes with immunosuppressive functions [84,85]. The gene discussed is CSF2; the disease is cancer.